The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
Nabi Tajima, who was the last known person to have been born in the 19th century, died in Japan after being in hospital since January.
Temperatures are predicted to reach a high of 23C.
Hunt accused companies of "turning a blind eye" to a generation of children "exposed to harmful emotional side effects" of social media.